Short description
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.
Description
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. Metagenomi forges these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific, and have a decreased risk of the immune response. Metagenomi's goal is to revolutionize gene editing for the benefit of patients around the world.
The company was founded in 2018 and is headquartered in Emeryville, California.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Emeryville, California, United States, North America
Founded on
January 1, 2018
Exited on
February 9
Went public on
February 9
Stock symbol
MGX
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Investors
Cannot Access, No Way, Noway Youcantaccess, Noway Youcantaccess, Cannot Access, Uh Ohhhh, Noaccess, Absolutely Noaccess, No Way, Noway Youcantaccess, Absolutely Noaccess, Nopepepe, Blurry Noaccess, Noaccess, Noaccess, Absolutely Noaccess, Uh Ohhhh, Nopepepe, Blurry Noaccess, Noaccess, Noway Youcantaccess, Blurry Noaccess, Nopepepe, Noaccess, Noaccess, Noaccessforu, Nopepepe, Nopepepe, Blurry Noaccess
Sign in for full access
Founders
Brian Thomas, Jillian Banfield